Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1186)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$572.25
Total Value
$183.12K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$571.23
Total Value
$182.79K
Shares Held After
40,833
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
616
Price
$569.94
Total Value
$351.08K
Shares Held After
41,153
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,682
Price
$569.03
Total Value
$957.10K
Shares Held After
41,769
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,211
Price
$568.07
Total Value
$1.82M
Shares Held After
43,451
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$567.04
Total Value
$1.06M
Shares Held After
46,662
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,477
Price
$566.19
Total Value
$836.26K
Shares Held After
48,536
% of Holdings
3.0%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
116
Price
$26.00
Total Value
$3.02K
Shares Held After
31,001
% of Holdings
0.4%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,822
Price
$26.00
Total Value
$47.37K
Shares Held After
381,073
% of Holdings
0.5%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
53,336
Price
$48.40
Total Value
$2.58M
Shares Held After
1,477,997
% of Holdings
3.5%
AC Immune SA (ACIU)
Pfeifer Andrea — Director
Shares
10,000
Price
$2.79
Total Value
$27.93K
Shares Held After
3,820,288
% of Holdings
0.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,500
Price
$20.29
Total Value
$91.31K
Shares Held After
191,641
% of Holdings
2.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
8,000
Price
$20.29
Total Value
$162.34K
Shares Held After
196,141
% of Holdings
3.9%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
13,100
Price
$6.65
Total Value
$87.11K
Shares Held After
700,000
% of Holdings
1.8%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200
Price
$13.95
Total Value
$2.79K
Shares Held After
910,143
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
100
Price
$13.80
Total Value
$1.38K
Shares Held After
909,943
% of Holdings
0.0%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
100
Price
$63.52
Total Value
$6.35K
Shares Held After
33,377
% of Holdings
0.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,100
Price
$62.42
Total Value
$131.09K
Shares Held After
33,477
% of Holdings
5.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
4,800
Price
$61.56
Total Value
$295.49K
Shares Held After
35,577
% of Holdings
11.9%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$57.04
Total Value
$1.43M
Shares Held After
1,198,095
% of Holdings
2.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,100
Price
$1.02
Total Value
$5.20K
Shares Held After
285,866
% of Holdings
1.8%
ABEONA THERAPEUTICS INC. (ABEO)
Crombez Eric — Director
Shares
26,143
Price
$5.53
Total Value
$144.64K
Shares Held After
37,313
% of Holdings
41.2%
NovaBridge Biosciences (NBP)
Cao Sean Wuxiong — Director
Shares
21,399
Price
$1.99
Total Value
$42.58K
Shares Held After
35,073
% of Holdings
37.9%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
15,000
Price
$26.22
Total Value
$393.35K
Shares Held After
0
% of Holdings
100.0%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
15,580
Price
$6.91
Total Value
$107.66K
Shares Held After
700,000
% of Holdings
2.2%
AbCellera Biologics Inc. (ABCL)
Montalbano John S. — Director
Shares
20,000
Price
$4.77
Total Value
$95.40K
Shares Held After
241,000
% of Holdings
8.3%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
300,000
Price
$1.20
Total Value
$360.00K
Shares Held After
311,547
% of Holdings
96.3%
Orchestra BioMed Holdings, Inc. (OBIO)
Fain Eric S — Director
Shares
20,000
Price
$4.13
Total Value
$82.60K
Shares Held After
91,709
% of Holdings
21.8%
Karyopharm Therapeutics Inc. (KPTI)
Paulson Richard A. — Director
Shares
2,203
Price
$9.50
Total Value
$20.93K
Shares Held After
269,747
% of Holdings
0.8%
Karyopharm Therapeutics Inc. (KPTI)
Mano Michael — EVP, CLO&Secretary
Shares
266
Price
$9.50
Total Value
$2.53K
Shares Held After
94,398
% of Holdings
0.3%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$58.62
Total Value
$1.47M
Shares Held After
1,223,095
% of Holdings
2.0%
Karyopharm Therapeutics Inc. (KPTI)
Cheng Sohanya Roshan — EVP & Chief Commercial Officer
Shares
324
Price
$9.50
Total Value
$3.08K
Shares Held After
107,940
% of Holdings
0.3%
Karyopharm Therapeutics Inc. (KPTI)
Rangwala Reshma — EVP & Chief Medical Officer
Shares
408
Price
$9.50
Total Value
$3.88K
Shares Held After
56,829
% of Holdings
0.7%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
53
Price
$9.50
Total Value
$503.50
Shares Held After
23,801
% of Holdings
0.2%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
10,479
Price
$117.54
Total Value
$1.23M
Shares Held After
64,910
% of Holdings
13.9%
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
403
Price
$9.50
Total Value
$3.83K
Shares Held After
94,821
% of Holdings
0.4%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
3,220
Price
$78.68
Total Value
$253.35K
Shares Held After
242,662
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$578.29
Total Value
$208.19K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
232
Price
$576.88
Total Value
$133.84K
Shares Held After
40,873
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
983
Price
$575.98
Total Value
$566.19K
Shares Held After
41,105
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,922
Price
$575.02
Total Value
$1.68M
Shares Held After
42,088
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,283
Price
$574.21
Total Value
$1.89M
Shares Held After
45,010
% of Holdings
6.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
744
Price
$572.90
Total Value
$426.24K
Shares Held After
48,293
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$572.04
Total Value
$320.34K
Shares Held After
49,037
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
376
Price
$571.04
Total Value
$214.71K
Shares Held After
49,597
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$568.69
Total Value
$22.75K
Shares Held After
49,973
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$578.59
Total Value
$46.29K
Shares Held After
18,876
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
307
Price
$577.93
Total Value
$177.42K
Shares Held After
18,956
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
293
Price
$576.75
Total Value
$168.99K
Shares Held After
19,263
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,712
Price
$575.78
Total Value
$985.74K
Shares Held After
19,556
% of Holdings
8.0%
Showing 251–300 of 1186 transactions (page 6 of 24)